Astex Pharmaceuticals Inc (ASTX.OQ)
ASTX.OQ on NASDAQ Stock Exchange Global Select Market
5.29USD
1 Aug 2013
5.29USD
1 Aug 2013
Price Change (% chg)
$0.06 (+1.15%)
$0.06 (+1.15%)
Prev Close
$5.23
$5.23
Open
$5.35
$5.35
Day's High
$5.37
$5.37
Day's Low
$5.29
$5.29
Volume
14,479
14,479
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
About
Astex Pharmaceuticals, Inc., formerly SuperGen, Inc. is a pharmaceutical company is primarily engaged in the discovery and development of small molecule therapeutics with a focus on oncology and hematology. The Company is developing a pipeline of medicines for partnership with pharmaceutical companies. The Company’s two lead... (more)
Overall
| Beta: | 1.15 |
| Market Cap (Mil.): | $494.78 |
| Shares Outstanding (Mil.): | 94.60 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ASTX.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 121.37 | 47.13 | 37.76 |
| EPS (TTM): | 0.04 | -- | -- |
| ROI: | 1.86 | -2.58 | 18.76 |
| ROE: | 1.93 | -2.66 | 19.59 |
BRIEF-Astex Pharmaceuticals shares up 1 pct after the bell following results
NEW YORK, April 29 - Astex Pharmaceuticals Inc : * Shares were up 1 percent after the bell following the release of its results.
BRIEF-Astex Pharmaceuticals shares up 8.3 pct premarket
NEW YORK, April 3 - Astex Pharmaceuticals Inc : * Shares up 8.3 percent in premarket trading
BRIEF-GIMV sells shares of Astex, Ablynx
BRUSSELS, March 11 - Gimv NV : * Astex stake sale has 0.04 per share positive impact on Gimv * Ablynx stake reduction has 0.07 per share positive impact on Gimv
Competitors
| Price | Change | |
|---|---|---|
| DAIICHI SANKYO COMPANY, LIMITED (4568.T) | ¥1,636 | +39.00 |
| Pfizer Inc. (PFE.N) | $29.29 | +0.06 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| Sanofi SA (SASY.PA) | €76.89 | -3.28 |
| GlaxoSmithKline plc (GSK.L) | 1,702.36p | +18.50 |
| Eli Lilly & Co. (LLY.N) | $53.31 | +0.20 |
| Bristol Myers Squibb Co. (BMY.N) | $43.61 | +0.37 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Celgene Corporation (CELG.OQ) | $148.00 | +1.14 |
| CrystalGenomics Inc. (083790.KQ) | ₩9,990.00 | -560.00 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

